News
- 2016/09/30
- Updated information of CSR
- 2016/07/05
- Results of Phase III study of NK105, a novel macromolecular micelle encapsulating an anticancer drug
- 2016/06/08
- Announcement: Establishment of Joint Venture Company for MAB Production
- 2016/06/06
- Notice Concerning Monthly Share Repurchase Results and Repurchase Completion
- 2016/06/05
- The 100th anniversary of the Nippon Kayaku Group’s founding is on June 5, 2016.
- 2016/04/27
- Nippon Kayaku Announces FDA Orphan Drug Designation to New Polymeric micelle Anti-Cancer Drug NK012 for Small Cell Lung Cancer
- 2016/03/30
- We have published "Nippon Kayaku Commemorating 100 Years of Sukima Ideas".